Literature DB >> 25448444

Effect of porcine circovirus type 2 (PCV2) load in serum on average daily weight gain during the postweaning period.

S López-Soria1, M Sibila2, M Nofrarías2, M Calsamiglia2, E G Manzanilla3, H Ramírez-Mendoza4, A Mínguez5, J M Serrano5, O Marín5, F Joisel6, C Charreyre6, J Segalés7.   

Abstract

Porcine circovirus type 2 (PCV2) is a ubiquitous virus that mainly affects nursery and fattening pigs causing systemic disease (PCV2-SD) or subclinical infection. A characteristic sign in both presentations is reduction of average daily weight gain (ADWG). The present study aimed to assess the relationship between PCV2 load in serum and ADWG from 3 (weaning) to 21 weeks of age (slaughter) (ADWG 3-21). Thus, three different boar lines were used to inseminate sows from two PCV2-SD affected farms. One or two pigs per sow were selected (60, 61 and 51 piglets from Pietrain, Pietrain×Large White and Duroc×Large White boar lines, respectively). Pigs were bled at 3, 9, 15 and 21 weeks of age and weighted at 3 and 21 weeks. Area under the curve of the viral load at all sampling times (AUCqPCR 3-21) was calculated for each animal according to standard and real time quantitative PCR results; this variable was categorized as "negative or low" (<10(4.3) PCV2 genome copies/ml of serum), "medium" (≥10(4.3) to ≤10(5.3)) and "high" (>10(5.3)). Data regarding sex, PCV2 antibody titre at weaning and sow parity was also collected. A generalized linear model was performed, obtaining that paternal genetic line and AUCqPCR 3-21 were related to ADWG 3-21. ADWG 3-21 (mean±typical error) for "negative or low", "medium" and "high" AUCqPCR 3-21 was 672±9, 650±12 and 603±16 g/day, respectively, showing significant differences among them. This study describes different ADWG performances in 3 pig populations that suffered from different degrees of PCV2 viraemia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Average daily weight gain; Genetics; PCV2-subclinical infection (PCV2-SI); PCV2-systemic disease (PCV2-SD); Porcine circovirus type 2 (PCV2); Viral load

Mesh:

Substances:

Year:  2014        PMID: 25448444     DOI: 10.1016/j.vetmic.2014.09.016

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Evaluation of natural porcine circovirus type 2 (PCV2) subclinical infection and seroconversion dynamics in piglets vaccinated at different ages.

Authors:  Salvador Oliver-Ferrando; Joaquim Segalés; Sergio López-Soria; Antonio Callén; Olivier Merdy; François Joisel; Marina Sibila
Journal:  Vet Res       Date:  2016-12-03       Impact factor: 3.683

2.  Comparison of serum pools and oral fluid samples for detection of porcine circovirus type 2 by quantitative real-time PCR in finisher pigs.

Authors:  Gitte Blach Nielsen; Jens Peter Nielsen; John Haugegaard; Sanne Christiansen Leth; Lars E Larsen; Charlotte Sonne Kristensen; Ken Steen Pedersen; Helle Stege; Charlotte K Hjulsager; Hans Houe
Journal:  Porcine Health Manag       Date:  2018-02-01

3.  Effect of Porcine circovirus 2 (PCV-2) maternally derived antibodies on performance and PCV-2 viremia in vaccinated piglets under field conditions.

Authors:  S Figueras-Gourgues; L Fraile; J Segalés; I Hernández-Caravaca; R López-Úbeda; F A García-Vázquez; O Gomez-Duran; B Grosse-Liesner
Journal:  Porcine Health Manag       Date:  2019-09-05

4.  First detection and full genomic analysis of Canine Circovirus in CPV-2 infected dogs in Colombia, South America.

Authors:  Sebastian Giraldo-Ramirez; Santiago Rendon-Marin; Diana S Vargas-Bermudez; Jairo Jaime; Julian Ruiz-Saenz
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

5.  Field evaluation of piglet vaccination with a Mycoplasma hyopneumoniae bacterin as compared to a ready-to-use product including porcine circovirus 2 and M. hyopneumoniae in a conventional French farrow-to-finish farm.

Authors:  Didier Duivon; Isabelle Corrégé; Anne Hémonic; Martial Rigaut; David Roudaut; Rika Jolie
Journal:  Porcine Health Manag       Date:  2018-01-18

6.  Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions.

Authors:  M Sibila; G Guevara; R Cuadrado; P Pleguezuelos; D Pérez; A Pérez de Rozas; E Huerta; A Llorens; O Valero; M Pérez; C López; R Krejci; J Segalés
Journal:  Porcine Health Manag       Date:  2020-05-04

Review 7.  Revisiting Porcine Circovirus Disease Diagnostic Criteria in the Current Porcine Circovirus 2 Epidemiological Context.

Authors:  Joaquim Segalés; Marina Sibila
Journal:  Vet Sci       Date:  2022-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.